Senior insider sale
Chief Operating Officer at NEUMORA THERAPEUTICS, INC. — senior position signals high conviction
$16.0K
9.54K shares
What this filing means
SUH CAROL Y. plans to sell 9.54K shares of NEUMORA THERAPEUTICS, INC. valued at approximately $16.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2025ACC: 0001964306-25-000081
Officer· Chief Operating Officer
Since Sep 2023
9.54K
Shares to sell
$16.0K
Approx. market value
9.54K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
2/14/2025
9.54KTotal acquired9.54K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/14/2025 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 9.54K | — |
| Total | 9.54K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
9.54K
Market value
$16.0K
2/18/2025
Total
Units
9.54K
Value
$16.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/18/2025 | 9.54K | $16.0K | NASDAQ | Planned |
| Total | 9.54K | $16.0K | ||